月度归档： 2026 年 6 月

Why it matters: Alexander disease (AxD) is a rare, progressive and often fatal neurological disorder caused by mutations in the GFAP gene. The disease affects astrocytes, critical support cells in the brain, leading to progressive loss of neurological function, including mobility, independence, swallowing and breathing. Symptoms vary by age of onset, and patients often die within 14–25 years after symptoms begin. There are currently no approved disease-modifying therapies for AxD.

Source: AlexRatha/Getty ImagesNew research headed by scientists at Baylor College of Medicine suggests that when bacteria are under antibiotic attack, it is not “every man for himself.” The team developed a genetic system in Escherichia coli to track how the cells transferred proteins between them. The results indicated that bacterial populations work as a team to survive antibiotics, pooling their resources and helping quiescent or dormant cells survive. Using different techniques, including high-resolution imaging, the team found that antibiotic treatment induced the transfer of proteins between different E. coli strains, and between E. coli and other species of bacteria.

June 2026, Singapore: Singapore has ranked among the world’s ten most resilient food systems in a latest study by …

By Editor, Global AgInvesting Media BTG Pacutal Timberland Investment Group (TIG), a timberland investment management organization, has acquired approximately 90,000 acres of U.S. timberland formerly managed by Jamestown, a global design-focused real estate investment and management firm. The transaction elevates TIG’s core U.S. timberland strategy portfolio to more than 1.7 million acres, contributing to the firm’s 3.3 million acres managed globally. The Jamestown timberland platform will be fully integrated into TIG’s core U.S. strategy.

Australian insect-waste startup Goterra has entered voluntary administration, with its administrator now seeking a buyer while keeping operations running at a reduced scale.

By the numbers: The Lausanne-based antibody-drug conjugate specialist said the reorganisation should generate about US$10m (€8.8m) in annualised savings. The company expects around US$3m (€2.6m) in one-time severance and related charges, mostly in the second quarter of 2026, and said its cash runway extends at least into 2028.

By Editor, Global AgInvesting MediaThe conversation around artificial intelligence often centers on Silicon Valley, autonomous vehicles, or generative text tools. However, one transformation driven by AI is happening far from the tech hubs—inside the barns of modern dairy farms.

June 2026, Washington: Today, the U.S. Department of Agriculture (USDA) released the annual Supplemental Nutrition Assis…

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life science value chain by expanding its presence in high-growth, next-generation life-sci markets with Bio-Techne’s tools, analytical technologies, and consumables.